Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
16 studies found for:    diabetes and eye and open and active | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
diabetes and eye and open and active | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Aflibercept;   Procedure: Endolaserless Vitrectomy
2 Recruiting PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs
Conditions: DIABETES;   DIABETIC RETINOPATHY;   DIABETIC NEUROPATHY
Intervention: Drug: CHOLESTYRAMINE
3 Recruiting Validation of an Integrated Attention Model for Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Behavioral: CAIPaDi
4 Recruiting Electrophysiologic Changes in Blacks Treated With CBT for Insomnia
Condition: Insomnia
Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia (CBT-I);   Behavioral: Self-Monitoring
5 Recruiting Noctura400 Treatment for Diabetic Retinopathy (CANDLE)
Condition: Diabetic Macular Oedema
Interventions: Device: Noctura 400 Eye Mask;   Drug: Ranibizumab
6 Recruiting Early Sleeve Gastrectomy In New Onset Diabetic Obese Patients
Condition: Type 2 Diabetes Mellitus
Interventions: Procedure: LSG;   Drug: CMT
7 Recruiting Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab
Conditions: Visual Acuity Reduced Transiently;   Macular Edema, Cystoid
Intervention: Drug: ranibizumab
8 Not yet recruiting Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study
Condition: Diabetic Macular Edema
Interventions: Drug: Tocilizumab;   Drug: Ranibizumab
9 Recruiting CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea
Conditions: Diabetic Retinopathy;   Sleep Apnea
Interventions: Device: Continuous positive airway pressure;   Drug: Pharmacological treatment;   Other: Conventional anti-diabetic diet recommendations
10 Recruiting Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa
Condition: Diabetic Macular Oedema
Interventions: Device: Navigated laser;   Device: Conventional laser
11 Recruiting Variable Interval Versus Set Interval Aflibercept for DME
Conditions: Cystoid Macular Edema;   Diabetic Macular Edema
Intervention: Drug: Intravitreal Aflibercept Injection
12 Recruiting Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
Conditions: Neovascularization;   Macular Degeneration;   Diabetic Retinopathy;   Retinal Vein Occlusion;   Choroidal Neovascularization;   Retinal Neovascularization;   Recurrent Pterygium;   Cystoid Macular Edema
Intervention: Drug: ziv-aflibercept
13 Recruiting Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
Conditions: Cushing's Disease;   Acromegaly
Interventions: Drug: Pasireotide s.c.;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Insulin;   Drug: Pasireotide LAR;   Drug: Metformin
14 Recruiting Adaptive Optics for Ophthalmic Technologies
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema
Intervention: Device: WF-AO-OCT
15 Recruiting Prevention of Microvascular Complications in Overweight Diabetics With Surgery or Best Medicine
Condition: Diabetic Kidney Disease
Interventions: Procedure: Optimal medical treatment and surgery;   Procedure: Optimal medical treatment
16 Recruiting Analysis of Aqueous and Vitreous Humor
Conditions: Proliferative Diabetic Retinopathy;   Macular Degeneration;   Macular Hole;   Neovascular Glaucoma
Interventions: Drug: Ranibizumab;   Other: No Ranibizumab

Study has passed its completion date and status has not been verified in more than two years.